Active ingredients: Paracetamol Codeine phosphate. Chemical names: N-(4-Hydroxyphenyl)acetamide 4,5a-epoxy-3-methoxy-17-methyl-7,8-
|
|
- Beverley Wilkerson
- 5 years ago
- Views:
Transcription
1 Codapane Paracetamol / Codeine phosphate PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredients: Paracetamol Codeine phosphate Chemical names: N-(4-Hydroxyphenyl)acetamide 4,5a-epoxy-3-methoxy-17-methyl-7,8- Structural formulas: didehydromorphinan-6a-ol phosphate Molecular formulas: C 8 H 9 NO 2 C 18 H 21 NO 3,H 3 PO 4,½H 2 O Molecular weights: CAS Registry No: DESCRIPTION Paracetamol is a white, crystalline powder, sparingly soluble in water, freely soluble in alcohol, very slightly soluble in methylene chloride. Codeine phosphate is a white, crystalline powder or small, colourless crystals, freely soluble in water, slightly soluble in alcohol, practically insoluble in ether. Each tablet contains the active ingredients paracetamol 500 mg and codeine phosphate 8 mg. The tablets also contain the following inactive ingredients; crospovidone, silica - colloidal anhydrous, stearic acid, magnesium stearate and sodium lauryl sulfate. The tablets are sugar-free, lactose-free and gluten-free. PHARMACOLOGY Paracetamol is a para-aminophenol derivative that exhibits analgesic and antipyretic activity. It does not possess anti-inflammatory activity. Codeine phosphate is an opioid analgesic which binds with stereo-specific receptors at many sites within the central nervous system. It alters processes affecting both the perception of pain and the emotional response to pain. Codeine has about one-sixth the analgesic activity of morphine.
2 Codapane Product Information 2 Pharmacokinetics Following oral administration, paracetamol is absorbed rapidly and completely from the gastrointestinal tract, with peak plasma concentrations occurring 10 to 60 minutes after administration. Paracetamol is uniformly distributed throughout most body fluids; the apparent volume of distribution is 1 to 1.2 L/kg. Paracetamol can cross the placenta and is excreted in breast milk. Plasma protein binding is negligible at usual therapeutic concentrations but increases with increasing concentrations. Paracetamol is metabolised by the hepatic microsomal enzyme system. In adults, at therapeutic doses, paracetamol is mainly conjugated with glucuronide (45 to 55%) or sulfate (20 to 30%). A minor proportion (less than 20%) is metabolised to catechol derivatives and mercapturic acid compounds via oxidation. Paracetamol is metabolised differently by infants and children compared to adults, the sulfate conjugate being predominant. Paracetamol is excreted in the urine mainly as the glucuronide and sulfate conjugates. Less than 5% is excreted as unchanged paracetamol with 85 to 90% of the administered dose eliminated in the urine within 24 hours of ingestion. The elimination half-life varies from 1 to 3 hours. Food intake delays paracetamol absorption. Codeine phosphate is absorbed from the gastrointestinal tract and peak plasma concentrations are reached 1 hour after oral administration. Codeine is metabolised in the liver to morphine and norcodeine. Codeine and its metabolites are excreted almost entirely by the kidney within 24 hours. The metabolites are mainly conjugates with glucuronic acid. Patients who metabolise drugs poorly via CYP2D6 are likely to obtain reduced benefit from codeine due to reduced formation of the active metabolite. The plasma half-life varies between 3 and 4 hours after oral administration. INDICATIONS For the temporary relief of moderate to severe pain and discomfort associated with headache, migraine headache, tension headache, earache, toothache, dental procedures, muscle pain, period pain, arthritis, rheumatics, osteoarthritis, back pain, neuralgia, sore throat and symptoms of cold and flu. Reduces fever and/or the discomfort associated with fever. CONTRAINDICATIONS Codapane is contraindicated in people with known hypersensitivity to paracetamol, codeine or excipients of Codapane. people with active alcoholism. people with acute respiratory depression.
3 Codapane Product Information 3 mothers who are breastfeeding, unless prescribed by a doctor (see PRECAUTIONS Use in Lactation). PRECAUTIONS Codapane is for the relief of minor and temporary ailment and should be used strictly as directed. Prolonged use without medical supervision could be harmful. Depending on the genetic variability of CYP2D6, the individual metabolising capacity for codeine may vary. Even therapeutic doses can lead to increased formation of the active metabolite morphine resulting in clinical signs of morphine intoxication (see OVERDOSAGE). Codeine should be administered with caution in patients with hypothyroidism, adrenocortical insufficiency (eg Addison s disease), shock, myxoedema, acute alcohol intoxication or delirium tremens since codeine may exacerbate the symptoms or increase the risk of respiratory and/or CNS depression. Hepatic/renal Dysfunction Codapane should be administered with caution to patients with hepatic or renal dysfunction. Opioid Dependence Prolonged use of high doses of codeine may produce dependence. Intracranial Pressure Codeine should be administered with great caution in patients with head injury, brain tumour or increased intracranial pressure since codeine may increase the risk of respiratory depression and further elevate intracranial pressure. In addition codeine can produce side effects such as confusion, miosis and vomiting which are important signs in following the clinical course of patients with head injuries. Decreased Respiratory Reserve Codeine should be administered with great caution in patients with decreased respiratory reserve (eg in emphysema, kyphoscoliosis, hypoxia, hypercapnia or even severe obesity) or cor pulmonale, or chronic obstructive pulmonary disease since codeine may exacerbate respiratory impairment. CNS Depression Codeine should be administered with great caution if at all in patients with CNS depression, since codeine may exacerbate the condition. Gastrointestinal Disorders Codeine should be administered with caution in patients with severe inflammatory bowel disease (risk of toxic megacolon may be increased, especially with repeated dosing). Codeine should be administered with caution in patients with acute abdominal conditions since codeine may obscure the diagnosis or the course of the disease.
4 Codapane Product Information 4 Monoamine Oxidase Inhibitors (MAOI s) Codeine should be administered with caution in patients taking Monoamine Oxidase Inhibitors (MAOI s) (see PRECAUTIONS - Interactions with Other Medicines). Seizures Codeine should be administered with caution in patients with a history of convulsive disorders (convulsions may be induced or exacerbated by codeine). Genitourinary Disorders. Codeine should be administered with caution in patients with prostatic hypertrophy, urethral stricture or recent urinary tract surgery since codeine may cause urinary retention. Use in Pregnancy (Category A) Codapane may be used during pregnancy on the advice of the doctor. However, it is recommended that nondrug therapies such as rest and massage are tried first. Australian categorisation definition of Category A. Drugs that have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the foetus having been observed. Use in Lactation Paracetamol is excreted in breast milk. Peak concentrations of 10 to 15 micrograms/ml have been measured within 1 to 2 hours of a single 650 mg maternal dose. The half-life of paracetamol in breast milk is 1.35 to 3.5 hours. Neither paracetamol or its metabolites were detected in the urine of breastfed infants following the maternal 650 mg dose. In nursing mothers, who are ultra-rapid metabolisers of codeine, higher than expected serum and breast milk morphine levels can occur. Morphine toxicity in babies can cause excessive somnolence, hypotonia and difficulty breastfeeding or breathing. In severe cases respiratory depression and death can occur. The lowest effective dose should be used, for the shortest possible time. Nursing mothers should be informed about carefully monitoring the infant during treatment for any sign and symptoms of morphine toxicity such as increased drowsiness or sedation, difficulty breastfeeding, breathing difficulties, and decreased tone, and should seek immediate medical care if such symptoms or signs are noticed. Codeine-containing products must not be used while breastfeeding unless prescribed by a doctor (see CONTRAINDICATIONS). Paediatric Use Not recommended for children under 7 years of age. Use in the Elderly Codeine should be used with caution in elderly or debilitated patients because of the danger of respiratory or cardiac depression.
5 Codapane Product Information 5 Interactions with Other Medicines Anticoagulants. Dose reduction of anticoagulants may be required if the treatment with Codapane is prolonged. Alcohol. Codeine may potentiate the effects of alcohol and the likelihood of toxicity may be increased by its concomitant use. The likelihood of paracetamol toxicity may also be increased by the concomitant use of alcohol with paracetamol. Opioid analgesics. Concurrent use of codeine and other opioid agonists is usually inappropriate as additive CNS depression, respiratory depressant and hypotensive effects may occur. Opioid agonists that decrease gastric emptying will decrease the absorption of paracetamol. Anticholinergics. Concomitant use of codeine and anticholinergic agents may increase the risk of severe constipation and/or urinary retention. Anticholinergics that decrease the gastric emptying, such as propantheline, will decrease the absorption of paracetamol. Monoamine oxidase inhibitors. Nonselective MAOIs intensify the effects of opioid drugs which can cause anxiety, confusion and significant respiratory depression. Severe and sometimes fatal reactions have occurred in patients concurrently administered MAO inhibitors and pethidine. Codeine should not be given to patients taking nonselective MAOIs or within 14 days of stopping such treatment. As it is unknown whether there is an interaction between the selective MAOIs (reversible inhibitors of monoamine oxidase A) and codeine, caution is advised with this drug combination. The absorption of paracetamol is decreased by MAO inhibitors that decrease gastric emptying. Metoclopramide. Drugs that increase gastric emptying, such as metoclopramide, may accelerate the absorption of paracetamol. Codeine may antagonise the effects of metoclopramide on gastrointestinal motility. Barbiturates and antiepileptic medications. The likelihood of toxicity may be increased by the concomitant use of enzyme inducing agents such as alcohol, barbiturates or antiepileptic drugs. Paracetamol Salicylates and NSAIDs. Prolonged concurrent use of paracetamol and salicylates or nonsteroidal antiinflammatory drugs may increase the risk of adverse renal effects. Diflunisal. Diflunisal may increase the plasma concentrations of paracetamol by 50%. Coumarins. Repeated high doses of paracetamol increase the anticoagulant response to coumarins. Chloramphenicol. Paracetamol may also increase chloramphenicol concentrations. Cholestyramine. Cholestyramine reduces the absorption of paracetamol if given within one hour of paracetamol administration.
6 Codapane Product Information 6 Codeine General anaesthetics. Codeine may potentiate the effects of general anaesthetics. Tranquillizers, sedatives and hypnotics. Concurrent use of codeine with these agents may enhance the potential respiratory depressant effects of codeine. CNS depressants. Codeine may potentiate the effects of CNS depressants. Antihypertensives. Hypotensive effects of antihypertensive agents may be potentiated when used concurrently with codeine and lead to orthostatic hypotension. Antiperistaltic antidiarrhoeals (including kaolin, pectin, loperamide). Concurrent use of these agents with codeine may increase the risk of severe constipation. Neuromuscular blocking agents. Codeine may enhance the effects of neuromuscular blocking agents resulting in increased respiratory depression. CYP2D6 enzyme inhibitors. Possible drug interactions between CYP2D6 inhibitors, such as quinidine, phenothiazines and antipsychotic agents, and codeine. Laboratory Tests Plasma amylase and lipase activity. Codeine may cause increased biliary tract pressure, thus increasing plasma amylase and/or lipase concentrations. Gastric emptying studies. Gastric emptying is delayed by codeine so gastric emptying studies will not be valid. Effect on Ability to Drive or Operate Machinery Codapane may cause drowsiness. Those affected should not drive or operate machinery. ADVERSE EFFECTS Adverse effects of Codapane tablets are generally infrequent and include the following. Haematological. Less frequent to rare. Agranulocytosis, anaemia, thrombocytopenia. Genitourinary. Less frequent to rare. Renal failure, uraemia, urinary retention or hesitancy. Hypersensitivity. Less frequent to rare. Skin rashes and other allergic reactions, histamine release (hypotension, flushing of the face, tachycardia, breathlessness). Gastrointestinal. Common. Constipation, dyspepsia, nausea, vomiting. Neurological. Common. Drowsiness, dizziness. Less frequent to rare. Euphoria, dysphoria. At higher doses codeine may cause respiratory depression.
7 Codapane Product Information 7 DOSAGE AND ADMINISTRATION Adults and Children over 12 years. One to two tablets, taken with water, every three to four hours if necessary (maximum eight tablets in 24 hours). Children (7 to 12 years). Half to one tablet, taken with water, every three to four hours if necessary (maximum four tablets in 24 hours). OVERDOSAGE Acute overdosage with Paracetamol, whether accidental or deliberate, is relatively common and can be extremely serious because of the narrow margin between therapeutic and toxic doses. Overdose can result in severe hepatic damage and sometimes acute renal tubular necrosis. Symptoms Toxic symptoms include vomiting, abdominal pain, hypotension, sweating, central stimulation with exhilaration and convulsions in children, drowsiness, respiratory depression, cyanosis and coma. In adults, hepatotoxicity may occur after ingestion of a single dose of paracetamol of 10 to 15 g (20-30 tablets); a dose of 25 g (50 tablets) or more is potentially fatal. Symptoms during the first two days of acute poisoning by paracetamol do not reflect the potential seriousness of the intoxication. Major manifestations of hepatic failure such as jaundice, hypoglycaemia and metabolic acidosis may take at least three days to develop. Treatment Prompt treatment is essential even when there are no obvious symptoms. If an overdose is taken or suspected, the Poisons Information Centre should be contacted immediately for advice (call ), or the patient should go to a hospital straight away, even if they feel well, because of the risk of delayed, serious liver damage. In cases of overdosage, methods of reducing absorption of ingested drug are important. Prompt administration of activated charcoal 50 g in 150 ml of water and 150 ml sorbitol 50% solution by mouth may reduce absorption. It is recommended that intravenous fluids such as Normal Saline be given concurrently. Gastric lavage is indicated if the patient is unwilling or unable to drink an activated charcoal/sorbitol mixture. If the history suggests that paracetamol 15 g or more has been ingested, administer the following antidote: Intravenous acetylcysteine 20%. Administer acetylcysteine immediately without waiting for positive urine test or plasma level results if 8 hours or less since overdose ingestion. Initial dose 150 mg/kg over 15 minutes, followed by continuous infusion of 50 mg/kg in glucose 5% 500 ml over four hours and 100 mg/kg in glucose 5% 1 L over 16 hours. If more than 8 hours have elapsed since the overdosage was taken, the antidote may be less effective.
8 Codapane Product Information 8 PRESENTATION AND STORAGE CONDITIONS Codapane, round, white tablet, marked P breakline C on one side, α on the reverse; blister pack, 10s*, 12s*, 20s*, 24s, 30s*, 36s* and 40s*. * Not marketed in Australia. Store below 30 C. POISON SCHEDULE OF THE MEDICINE S3 (Pharmacist Only Medicine) NAME AND ADDRESS OF THE SPONSOR Alphapharm Pty Limited (ABN ) Chase Building 2 Wentworth Park Road Glebe NSW DATE OF APPROVAL Approved by the Therapeutic Goods Administration on 25 March Date of most recent amendment: 15 April 2010.
PRODUCT INFORMATION CODAPANE XTRA Paracetamol 500 mg and Codeine Phosphate 15 mg Tablets
PRODUCT INFORMATION CODAPANE XTRA Paracetamol 500 mg and Codeine Phosphate 15 mg Tablets NAME OF THE MEDICINE Active Ingredients: Paracetamol and Codeine Phosphate Paracetamol: Molecular Formula: C 8 H
More informationMolecular formula: Molecular weight: C 8 H 9 NO 2 CAS Registry no.:
Parapane Paracetamol PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Chemical name: Paracetamol N-(4-hydroxyphenyl) Structural formula: Molecular formula: 151.20 Molecular weight: C 8 H 9 NO
More informationPanadeine Tablet, Caplets and Rapid Soluble tablets PRODUCT INFORMATION
Panadeine Tablet, Caplets and Rapid Soluble tablets PRODUCT INFORMATION DESCRIPTION Active Ingredients Paracetamol 500 mg Codeine Phosphate 8 mg Excipients Tablets - Starch - maize, talc - purified, stearic
More informationPRODUCT INFORMATION. (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
NORGESIC Orphenadrine citrate and paracetamol PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Chemical name: CAS number: 4682-36-4 Chemical structure: Orphenadrine citrate (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine
More informationPRODUCT INFORMATION Panadeine EXTRA
PRODUCT INFORMATION Panadeine EXTRA COMPOSITION Each caplet brand of capsule-shaped tablet contains: Paracetamol 500 mg Codeine phosphate 15 mg and Maize Starch Purified Talc Pregelatinised Maize Starch
More informationPRODUCT INFORMATION PANADEINE FORTE
PRODUCT INFORMATION PANADEINE FORTE NAME OF THE MEDICINE Non-proprietary Name Paracetamol and codeine phosphate DESCRIPTION Each capsule-shaped tablet contains Paracetamol 500 mg, Codeine phosphate 30
More informationPRODUCT INFORMATION MERSYNDOL FORTE TABLETS
PRODUCT INFORMATION MERSYNDOL FORTE TABLETS NAME OF THE MEDICINE Non-proprietary Name Paracetamol, codeine phosphate and doxylamine succinate DESCRIPTION Each tablet contains paracetamol 450 mg, codeine
More informationPRODUCT INFORMATION PRODEINE 15 H 3 CO. Paracetamol MW Codeine phosphate MW
PRODUCT INFORMATION PRODEINE 15 NAME OF THE MEDICINE Non-proprietary Name Paracetamol and codeine phosphate. Chemical Structure HO O H N CH 3 NH CH 3 H H 3 CO Paracetamol MW 151.17 Codeine phosphate MW
More informationAPO-PARACETAMOL/CODEINE 500/30
APO-PARACETAMOL/CODEINE 500/30 NAME OF THE MEDICINE Paracetamol/Codeine 500/30. Chemical Name: Paracetamol: N-(4-Hydroxyphenyl) acetamide Codeine: (5R, 6S)-7, 8-didehydro-4,5-epoxy-3-methoxy-Nmethylmorphinan-6-ol
More informationPRODUCT INFORMATION APOHEALTH PARACETAMOL PLUS CODEINE & CALMATIVE paracetamol 500mg codeine phosphate 10mg and doxylamine succinate 5.
Product Information Page 1 PRODUCT INFORMATION APOHEALTH PARACETAMOL PLUS CODEINE & CALMATIVE paracetamol 500mg codeine phosphate 10mg and doxylamine succinate 5.1mg tablets NAME OF THE MEDICINE Paracetamol
More informationPRODUCT INFORMATION APO-Paracetamol/Codeine 500/30
PRODUCT INFORMATION APO-Paracetamol/Codeine 500/30 NAME OF THE MEDICINE Non-proprietary Name Paracetamol and codeine phosphate Chemical Structure Paracetamol MW 151.17 Codeine phosphate MW 406.37 CAS Numbers
More informationPRODUCT INFORMATION PANADOL COLD & FLU MAX HOT LEMON POWDER NAME OF THE MEDICINE. Chemical structure: CAS 2 Registry Number: DESCRIPTION
PRODUCT INFORMATION PANADOL COLD & FLU MAX HOT LEMON POWDER NAME OF THE MEDICINE Active ingredient: Paracetamol Chemical structure: CAS 2 Registry Number: 103-90-2 DESCRIPTION Paracetamol is a white, crystalline
More informationAUSTRALIAN PRODUCT INFORMATION, PAINSTOP DAY-TIME PAIN RELIEVER (PARACETAMOL 120MG IN 5ML AND CODEINE PHOSPHATE HEMIHYDRATE 5MG IN 5ML)
AUSTRALIAN PRODUCT INFORMATION, PAINSTOP DAY-TIME PAIN RELIEVER (PARACETAMOL 120MG IN 5ML AND CODEINE PHOSPHATE HEMIHYDRATE 5MG IN 5ML) 1. NAME OF THE MEDICINE Paracetamol and codeine phosphate hemihydrate.
More informationNEW ZEALAND DATA SHEET. Each Paracetamol + Codeine contains 500 mg of paracetamol and 8 mg of codeine phosphate.
NEW ZEALAND DATA SHEET PARACETAMOL + CODEINE 1. Product Name Paracetamol + Codeine, 500 mg + 8 mg, tablets. 2. Qualitative and Quantitative Composition Each Paracetamol + Codeine contains 500 mg of paracetamol
More informationPARACOD Tablets (Paracetamol + Codeine phosphate)
Published on: 22 Sep 2014 PARACOD Tablets (Paracetamol + Codeine phosphate) Composition PARACOD Tablets Each effervescent tablet contains: Paracetamol IP...650 mg Codeine Phosphate IP... 30 mg Dosage Form/s
More informationRAFEN PLUS Ibuprofen 200mg/Codeine phosphate 12.8mg tablets PRODUCT INFORMATION
RAFEN PLUS Ibuprofen 200mg/Codeine phosphate 12.8mg tablets PRODUCT INFORMATION Composition RAFEN PLUS tablet is a white to off-white capsule-shaped, biconvex tablet, containing ibuprofen 200mg and codeine
More informationPRODUCT INFORMATION. Codral* Original Cold & Flu Tablets
PRODUCT INFORMATION Codral* Original Cold & Flu Tablets Product description Codral* Original Cold & Flu tablets contain paracetamol 500 mg, pseudoephedrine hydrochloride 30 mg and codeine phosphate 6 mg.
More informationPRODUCT INFORMATION ACTACODE
PRODUCT INFORMATION ACTACODE NAME OF THE MEDICINE Actacode codeine linctus contains codeine phosphate 5 mg/ml. Codeine phosphate is (5R,6S)-7,8-didehydro-4,5-epoxy-3-methoxy-N-methylmorphinan-6-ol dihydrogen
More informationYour Pharmacy Paracetamol Plus, capsule shaped tablets (caplets)
New Zealand Data Sheet Product Description Your Pharmacy Plus, capsule shaped tablets (caplets) 500 mg per tablet & Codeine Phosphate 10 mg per tablet Blister packs of white, capsule-shaped tablets Composition
More informationPANADOL EXTRA PRODUCT INFORMATION
PANADOL EXTRA PRODUCT INFORMATION DESCRIPTION Active Ingredients: Paracetamol 500 mg and Caffeine 65mg per tablet. Excipients: Maize starch Starch - Pregelatinised maize Povidone Potassium sorbate Purified
More informationNEW ZEALAND DATASHEET
NEW ZEALAND DATASHEET COLDREX HOT REMEDY COLD & FLU HOT LEMON Powder for Oral Solution Paracetamol (BP) 1000mg/sachet Presentation Pale yellow, free flowing heterogeneous powder with and odour of lemon
More informationMetabolism Paracetamol is metabolised in the liver and excreted in the urine mainly as glucuronide and sulphate conjugates.
FEBRAMOL Composition Febramol 150 Suppositories Each suppository contains Paracetamol 150 mg. Suppositories, Tablets & Syrup Febramol 300 Suppositories Each suppository contains Paracetamol 300 mg. Each
More informationPANADOL COLD & FLU MAX HOT LEMON Powder for Oral Solution DATA SHEET
PANADOL COLD & FLU MAX HOT LEMON Powder for Oral Solution Paracetamol (BP) 1000mg/sachet DATA SHEET Presentation Pale yellow, free flowing heterogeneous powder with and odour of lemon Indications Fast,
More informationAUSTRALIAN PRODUCT INFORMATION PANADOL OPTIZORB TABLETS (PARACETAMOL) TABLETS PANADOL OPTIZORB CAPLETS (PARACETAMOL) TABLETS
AUSTRALIAN PRODUCT INFORMATION PANADOL OPTIZORB TABLETS (PARACETAMOL) TABLETS PANADOL OPTIZORB CAPLETS (PARACETAMOL) TABLETS 1 NAME OF THE MEDICINE Paracetamol 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationPACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES
PACKAGE INSERT TEMPLATE FOR PARACETAMOL SUPPOSITORIES Brand or Product Name [Product name] Suppositories mg Name and Strength of Active Substance(s) Eg Paracetamol 500mg Paracetamol 250mg Paracetamol 125mg
More informationPANADOL COLD & FLU RELIEF ORIGINAL FORMULA is a white, capsule-shaped tablet with flat edges, one face marked with C&F, PANADOL on the other.
Product description PANADOL COLD & FLU RELIEF ORIGINAL FORMULA is a white, capsule-shaped tablet with flat edges, one face marked with C&F, PANADOL on the other. Ingredients Active Ingredients: Paracetamol
More informationParacetamol, codeine phosphate hemihydrate and promethazine hydrochloride.
AUSTRALIAN PRODUCT INFORMATION, PAINSTOP NIGHT-TIME PAIN RELIEVER (PARACETAMOL 120MG IN 5ML,CODEINE PHOSPHATE HEMIHYDRATE 5MG IN 5ML AND PROMETHAZINE HYDROCHLORIDE 6.5MG IN 5ML) 1. NAME OF THE MEDICINE
More informationPRODUCT INFORMATION. Ammonium chloride is an expectorant that has an irritant effect on mucous membranes.
PRODUCT INFORMATION BENADRYL Original Oral Liquid (New Formula) Name of the Medicine Diphenhydramine hydrochloride Ammonium chloride The chemical name for diphenhydramine hydrochloride is 2-(diphenylmethoxy)-N,Ndimethylethanamine
More informationPRODUCT INFORMATION. Sudafed* Sinus Day + Night Relief Tablets
PRODUCT INFORMATION Sudafed* Sinus Day + Night Relief Tablets Product description Sudafed* Sinus Day + Night Relief tablets contain two separate formulations: day tablets and night tablets. Each Sudafed*
More informationPRODUCT INFORMATION PRODEINE FORTE H 3 CO. Paracetamol MW Codeine phosphate hemihydrate MW
PRODUCT INFORMATION PRODEINE FORTE NAME OF THE MEDICINE Australian Approved Name Paracetamol and codeine phosphate hemihydrate Chemical Structure H N CH 3 HO O H.H 3 PO 4. 1/2 H 2 0 NH CH 3 H 3 CO Paracetamol
More informationMigraleve, Migraleve Pink and Migraleve Yellow Product Information
Migraleve, Migraleve Pink and Migraleve Yellow Product Information Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard Adverse events should also
More informationDATA SHEET. PANADOL Mini Caps Capsule shaped tablet with a gelatin coating which is one half green and the other half white.
PANADOL TABLETS PANADOL MINI CAPS DATA SHEET Proprietary (Trade) Name: PANADOL Active ingredient: Paracetamol (BP) 500 mg/tablet PRESENTATIONS White, film-coated tablet with bevelled edge, shallow convex,
More informationSANDOMIGRAN (pizotifen malate)
SANDOMIGRAN (pizotifen malate) S N CH 3 Pizotifen. COOH CH OH CH 2 COOH MALATE DESCRIPTION Pizotifen is a cycloheptathiophene derivative structurally related to cyproheptadine and the tricyclic antidepressants.
More informationMetomax Paracetamol and Metoclopramide (as hydrochloride)
Metomax Paracetamol and Metoclopramide (as hydrochloride) PRODUCT INFORMATION Name of the Medicine Active ingredients: Paracetamol Metoclopramide hydrochloride Structural formulas: Chemical names: N-(4-hydroxyphenyl)acetamide
More informationPANADOL SINUS DAY & NIGHT TABLETS PRODUCT INFORMATION
Product description PANADOL SINUS DAY tablet is a white, film-coated capsule-shaped tablet with flat edges, front and back faces marked with DAY. PANADOL SINUS NIGHT tablet is a white, film-coated round
More informationPRODUCT INFORMATION PANADOL TABLETS PANADOL MINI CAPS PANADOL SUPPOSITORIES
PRODUCT INFORMATION PANADOL TABLETS PANADOL MINI CAPS PANADOL SUPPOSITORIES NAME OF THE MEDICINE Active ingredients Chemical structure CAS Registry Number Paracetamol 103-90-2 DESCRIPTION Paracetamol is
More informationPRODUCT INFORMATION LOFENOXAL
PRODUCT INFORMATION LOFENOXAL Diphenoxylate hydrochloride 2.5 mg and Atropine sulfate 25 microgram Name of the medicines Diphenoxylate Hydrochloride: C30H32N2O2, HCl M. W. = 489.1 CAS registry no.: 3810-80-8
More informationPRODUCT INFORMATION ANAGRAINE. Each ANAGRAINE tablet contains 5 mg metoclopramide and 500 mg paracetamol.
PRODUCT INFORMATION ANAGRAINE COMPOSITION Each ANAGRAINE tablet contains 5 mg metoclopramide and 500 mg paracetamol. ACTIONS Metoclopramide stimulates gastrointestinal tract motility and accelerates gastric
More informationPANADOL OSTEO PRODUCT INFORMATION
PANADOL OSTEO PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredients Chemical structure CAS Registry Number Paracetamol 103-90-2 DESCRIPTION White to off-white film coated capsule shaped tablets with
More informationSCHEDULING STATUS: S0 For pack sizes of 24 tablets or less. For pack sizes of more than 24 tablets
SCHEDULING STATUS: S0 For pack sizes of 24 tablets or less S1 For pack sizes of more than 24 tablets PROPRIETARY NAME: AND DOSAGE FORM PANADO MELTABS (Tablets) COMPOSITION: Each tablet contains 500 mg
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME PANADOL TABLETS, Paracetamol 500 mg, film coated tablet PANADOL MINI CAPS, Paracetamol 500 mg, coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: Paracetamol (BP)
More informationPRODUCT INFORMATION. Sudafed* Sinus Day + Night Relief Tablets
PRODUCT INFORMATION Sudafed* Sinus Day + Night Relief Tablets Name of the Medicine Paracetamol CAS 2 Registry Number: 103-90-2 Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 Triprolidine
More informationLEAFLET: INFORMATION FOR THE USER. Freshalgin 500th mg tablets Metamizole sodium (M etamizol sodium)
LEAFLET: INFORMATION FOR THE USER Freshalgin 500th mg tablets Metamizole sodium (M etamizol sodium) Read this leaflet carefully before you start taking this medicine. This medicine is available without
More informationPRODUCT INFORMATION. Sudafed* Sinus + Allergy & Pain Relief Tablets
PRODUCT INFORMATION Sudafed* Sinus + Allergy & Pain Relief Tablets Name of the Medicine Paracetamol CAS 2 Registry Number: 103-90-2 Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 Triprolidine
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each capsule contains PARACETAMOL 500mg For a full list of excipients, see section 6.1.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PARACETAMOL 500mg CAPSULES Boots Paracetamol 500mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains PARACETAMOL
More informationNEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.
1. PRODUCT NAME ACUPAN 30 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nefopam hydrochloride 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM
More informationPRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets
PRODUCT INFORMATION SUDAFED Sinus 12 Hour Relief Tablets NAME OF THE MEDICINE Pseudoephedrine Hydrochloride CAS 2 Registry Number: 345-78-8 DESCRIPTION SUDAFED Sinus 12 Hour Relief prolonged-release tablets
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1. Name of Medicinal Product Co-Codamol 8/500 mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol 500.0 mg Codeine Phosphate 8.0 mg For excipients, see section 6.1 3 PHARMACEUTICAL FORM
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME Sudomyl, Tablet, 60 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substance Pseudoephedrine Hydrochloride 60mg Excipient(s) with known effect For the full
More informationCHILDREN S PANADOL COLOURFREE SUSPENSION PANADOL SUPPOSITORIES 125 MG PANADOL SUPPOSITORIES 250 MG DATA SHEET. Proprietary (Trade) Name: PANADOL
CHILDREN S PANADOL COLOURFREE SUSPENSION PANADOL SUPPOSITORIES 125 MG PANADOL SUPPOSITORIES 250 MG DATA SHEET Proprietary (Trade) Name: PANADOL Active ingredient: Paracetamol (BP) 120 mg/5ml (Children
More informationAPO-Paracetamol/Codeine 500/30 Contains the active ingredients, paracetamol and codeine phosphate
APO-Paracetamol/Codeine 500/30 Contains the active ingredients, paracetamol and codeine phosphate Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet
More informationChemists Own Strong Pain Extra Paracetamol and Codeine Phosphate
Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate Consumer Medicine Information(CMI) Please read this information before you start taking this medicine. What is in this CMI? This CMI answers
More informationNAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.
NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon-A contains naphazoline hydrochloride
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Tipol 75mg Suppositories Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 75mg of paracetamol For a full list of excipients,
More informationPIL. ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid
PIL ParaCet Flu 500 mg+250 mg/sachet Powder for oral solution paracetamol + ascorbic acid Please, carefully read this PIL before you start using the medicine. This medicine is available without prescription,
More informationPRODUCT INFORMATION. Sudafed* Sinus + Anti-inflammatory Pain Relief Caplets
PRODUCT INFORMATION Sudafed* Sinus + Anti-inflammatory Pain Relief Caplets Product description Sudafed* Sinus + Anti-inflammatory Pain Relief caplets contain pseudoephedrine hydrochloride 30 mg and ibuprofen
More informationPRODUCT INFORMATION H 3 CO. paracetamol MW codeine phosphate hemihydrate MW
RODUCT INFORMATION RODEINE NAME OF THE MEDICINE Non-proprietary Name aracetamol, codeine phosphate hemihydrate Chemical Structure H N CH 3 HO O H.H 3 O 4. 1/2 H 2 0 NH CH 3 H 3 CO paracetamol MW 151.17
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Paracetamol 80mg Suppositories 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each suppository contains 80mg Paracetamol For a full list of
More informationEach 5ml of Sinarest LP New Syrup contains: Phenylephrine
Composition: Each 5ml of Sinarest LP New Syrup contains: Paracetamol Phenylephrine Levocetrizine 250mg 5mg 1.25mg Pharmacokinetic properties: Paracetamol is readily absorbed from the gastrointestinal tract
More informationAUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM
AUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 1 NAME OF THE MEDICINE Betahistine dihydrochloride. 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM
More informationPRODUCT INFORMATION. Active ingredients Chemical structure CAS Registry Number. Paracetamol
PRODUCT INFORMATION PANADOL SINUS PAIN & CONGESTION RELIEF CAPLETS PANADOL COLD & FLU PLUS DECONGESTANT CAPLETS NAME OF THE MEDICINE Active ingredients Chemical structure CAS Registry Number Paracetamol
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Aciclovir Pharmaceutical form(s)/strength: Tablets 200, 400 or 800 mg Dispersible tablets 200, 400 or 800 mg Oral suspensions 200 mg or 400 mg per 5 ml. Freeze
More informationNow available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet
Now available SUBOXONE Once-daily dosing1 12 mg and 16 mg tablets A maintenance dose of SUBOXONE 12-16 mg once daily is clinically effective for most patients*1 Effective maintenance dosing with SUBOXONE
More informationDATA SHEET. Paracetamol (BP) 500 mg and Phenylephrine Hydrochloride (BP) 5 mg
COLDREX PE PHENYLEPHRINE SINUS COLDREX PE PHENYLEPHRINE CONGESTION CLEAR PANADOL SINUS PAIN & CONGESTION RELIEF PANADOL COLD & FLU MAX + DECONGESTANT DATA SHEET Paracetamol (BP) 500 mg and Phenylephrine
More informationPRODUCT INFORMATION. AKINETON (biperiden hydrochloride 2 mg tablets)
PRODUCT INFORMATION AKINETON (biperiden hydrochloride 2 mg tablets) NAME OF THE MEDICINE Non-proprietary name: biperiden hydrochloride Structural formula (biperiden): Chemical name (biperiden): α-5-norbornen-2-yl-α-phenyl-1-piperidine
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Panadol Baby 120 mg/5 ml, Oral Suspension. Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml spoonful of suspension contains paracetamol
More informationNOTOPAIN CAPLETS. Diclofenac Sodium + Paracetamol. Composition. Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg.
NOTOPAIN CAPLETS Diclofenac Sodium + Paracetamol Composition Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg Pharmacology Phamacodynamics Diclofenac relieves pain and inflammation
More informationTRAPADOL INJECTION FOR I.V./I.M. USE ONLY
TRAPADOL INJECTION FOR I.V./I.M. USE ONLY Composition : Each 2ml. contains : Tramadol Hydrochloride I.P. Water for injection I.P. 100mg. q.s. CLINICAL PHARMACOLOGY : Pharmacodynamics Tramadol is a centrally
More informationEuropean PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam
European PSUR Work Sharing Project CORE SAFETY PROFILE Lendormin, 0.25mg, tablets Brotizolam 4.2 Posology and method of administration Unless otherwise prescribed by the physician, the following dosages
More informationPRODUCT INFORMATION. Active ingredients Chemical structure CAS Registry Number. Paracetamol
PRODUCT INFORMATION PANADOL COLD & FLU MAX + DECONGESTANT HOT LEMON POWDER NAME OF THE MEDICINE Active ingredients Chemical structure CAS Registry Number Paracetamol 103-90-2 Phenylephrine Hydrochloride
More informationPanafen Plus PRODUCT INFORMATION
Panafen Plus PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Ibuprofen Codeine phosphate Ibuprofen Chemical structure: Chemical name: 2-(4-isobutylphenyl) propionic acid Molecular formula:
More informationPRODUCT INFORMATION. Codral* Original Cold & Flu + Cough Day & Night Capsules
PRODUCT INFORMATION Codral* Original Cold & Flu + Cough Day & Night Capsules Description Codral* Original Cold & Flu + Cough Day & Night capsules contain two separate formulations: day capsules and night
More informationCORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/ January 2013
CORE SAFETY PROFILE OXYCODONE HYDROCHLORIDE NL/H/PSUR/0054/001 16 January 2013 1 4.2 Posology and method of administration (safety aspects only) Posology Elderly patients For oral preparations A dose adjustment
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Co-Codamol 8mg/500mg Tablets Boots Paracetamol and Codeine Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol 500mg Codeine
More informationNEW ZEALAND DATA SHEET
NEW ZEALAND DATA SHEET 1. PRODUCT NAME PANADOL Extra (reformulation), Paracetamol 500 mg and Caffeine 65 mg, film coated tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredients: Paracetamol
More informationPRODUCT INFORMATION. Parke Davis* Day & Night Original Cough Cold & Flu Capsules
PRODUCT INFORMATION Parke Davis* Day & Night Original Cough Cold & Flu Capsules Product description Parke Davis* Day & Night Original Cough Cold & Flu capsules contain two separate formulations: day capsules
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Maxilief Effervescent Tablets Paracetamol 500mg Codeine Phosphate Hemihydrate 8mg Caffeine 30mg Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
More informationPRODUCT INFORMATION. Benadryl* for the Family Nightime Oral Liquid
Product description PRODUCT INFORMATION Benadryl* for the Family Nightime Oral Liquid Each 5 ml of Benadryl* Nightime oral liquid contains dextromethorphan hydrobromide 10 mg and diphenhydramine hydrochloride
More informationPRODEINE paracetamol and codeine phosphate hemihydrate
PRODEINE paracetamol and codeine phosphate hemihydrate Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Prodeine. It does not, however, contain
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Comfora 595 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains: glucosamine sulphate
More informationAVIOMARIN 50 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER AVIOMARIN 50 mg tablets DIMENHYDRINATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPRESCRIBING INFORMATION CALMYLIN ACE. Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup
PRESCRIBING INFORMATION CALMYLIN ACE Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup Guaifenesin 100 mg/5 ml - Codeine Phosphate 10 mg/5 ml Pheniramine Maleate 7.5 mg/5 ml Expectorant/ Cough
More informationSUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS
SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS Guideline Title Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics Legislative basis Directive
More informationNEW ZEALAND DATA SHEET
NEW ZEALAND DATA SHEET VERGO 16 1. Product Name Vergo 16, 16 mg, tablet. 2. Qualitative and Quantitative Composition Each tablet contains 16 mg of betahistine dihydrochloride. For the full list of excipients,
More informationMOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350)
MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350) NAME OF THE MEDICINE: MOVICOL Liquid Orange Flavour, Concentrate for Oral Solution. DESCRIPTION: A clear colourless solution.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cyklonova 500 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Tranexamic acid 500 mg. For the full list of excipients,
More informationDBL NALOXONE HYDROCHLORIDE INJECTION USP
Name of medicine Naloxone hydrochloride Data Sheet New Zealand DBL NALXNE HYDRCHLRIDE INJECTIN USP Presentation DBL Naloxone Hydrochloride Injection USP is a sterile, clear, colourless solution, free from
More informationFarmadol. Paracetamol 10 mg/ml INFUSION SOLUTION
Farmadol Paracetamol 10 mg/ml INFUSION SOLUTION Composition Each ml contains: Paracetamol 10 mg Pharmacology Pharmacodynamic properties The precise mechanism of the analgesic and antipyretic properties
More informationNew Zealand Datasheet
1. NAME OF MEDICINE PANAFEN PLUS New Zealand Datasheet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredients: Ibuprofen 200 mg, codeine phosphate 12.8 mg 3. PHARMACEUTICAL FORM Ibuprofen Chemical
More informationPatient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol
Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this
More informationNEW ZEALAND DATA SHEET
1. PRODUCT NAME Codeine Phosphate Tablets (PSM) 15 mg, 30 mg & 60 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substance Codeine Phosphate Hemihydrate BP 15 mg
More informationNausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules.
Nausicalm Cyclizine lactate 50 mg/ml solution for injection Presentation Nausicalm solution for injection is a clear colourless solution, presented in 1 ml ampoules. Uses Actions Cyclizine is a piperazine
More informationPRODUCT INFORMATION ANAMORPH
PRODUCT INFORMATION ANAMORPH NAME OF DRUG ANAMORPH Tablets contain morphine sulfate 30 mg. DESCRIPTION Morphine is a phenanthrene-derivative opiate agonist. Morphine is the chief opium alkaloid which is
More informationPanafen Plus Product Information
Panafen Plus Product Information COMPOSITION Actives: Ibuprofen 200 mg, codeine phosphate 12.8 mg Inactives: cellulose-microcrystalline, vegetable oil-hydrogenated, sodium starch glycollate, silica-colloidal
More informationElements for a Public Summary
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Sudden pain is an unpleasant sensation resulting from physical hurt caused by injuries of the body, illness or emotional illness.
More informationBRICANYL INJECTION. terbutaline sulfate PRODUCT INFORMATION
BRICANYL INJECTION terbutaline sulfate PRODUCT INFORMATION NAME OF THE MEDICINE Terbutaline sulfate, 2-(tert-butylamino)-1-(3,5-dihydroxyphenyl) ethanol sulfate, a sympathomimetic bronchodilator with a
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT PARACETAMOL 500mg CAPSULES 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Paracetamol 500mg For the full list of excipients see section6.1.
More informationSUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dihydrocodeine 30mg Tablets BP. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains dihydrocodeine tartrate 30 mg Also contains
More informationLorazepam Tablets, USP
Lorazepam Tablets, USP DESCRIPTION: Lorazepam, an antianxiety agent, has the chemical formula, 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H -1,4-benzodiazepin-2-one: Cl H N N O Cl OH It is a white
More information